Global Sinus Dilation Devices Market

Sinus Dilation Devices Market Size, Share, Growth Analysis, By Product(Balloon Sinus Dilation Devices, Endoscopes [Sinuscopes, Rhinoscopes], Sinus Stents/Implants), By Procedure(Standalone Sinus Dilation Procedures, Hybrid Sinus Dilation Procedures), By Patient Type(Adult Patients, Paediatric Patients), By Patient Care Setting(Hospitals and Ambulatory Surgery Centers, ENT Clinics), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2791 | Region: Global | Published Date: September, 2024
Pages: 219 | Tables: 86 | Figures: 76

Sinus Dilation Devices Market News

  • May 2022: Delent Medical received additional patent protection for its Sinusleave balloon device, which also protects the company’s proprietary device and strategic balloon sinus dilatation system for the treatment of chronic sinusitis. 
  • May 2022: Medtronic completes the acquisition of Intersect ENT to expand its ear, nose and throat (ENT) division with new products used in sinus treatment. 
  • In July 2022, high-performance, single-use endoscope manufacturer Zsquare received an FDA 510K license to market its first product, the Zsquare ENT-Flex Rhinolaryngoscope Zsquare plans to bring research to the US. So that product launches demand product availability increase, leading to market growth.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Sinus Dilation Devices Market size was valued at USD 2.70 billion in 2022 and is poised to grow from USD 2.88 billion in 2023 to USD 4.76 billion by 2031, growing at a CAGR of 6.50% during the forecast period (2024-2031).

The sinus dilation devices market is a competitive one, with various key players applying strategies, innovations, and advanced technologies to maintain their market position. A leading global medical technology company, Medtronic offers a variety of sinus dilation devices, including balloon sinus dilation systems. Medtronic partnered with the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) to provide educational materials and training for ENT surgeons. This collaboration facilitates the development of validated Medtronic sinus dilation technology great and promotes best practices in sinus surgery.  'Entellus Medical, Inc. (US) (Subsidiary of Stryker) ', 'Medtronic PLC (Ireland) ', 'Acclarent, Inc. (US) (Subsidiary of Johnson & Johnson) ', 'Smith & Nephew PLC (UK) ', 'Intersect ENT, Inc. (US) ', 'Olympus Corporation (Japan) ', 'Sinusys Corporation (US) ', 'Innaccel Technologies Pvt Ltd. (India) ', 'Meril Life Sciences Pvt. Ltd. (India) ', 'Optim LLC (US) ', 'Jilin Coronado Medical Ltd. (China) ', 'Dalent Medical (US) ', 'Emos Technology GmbH (Germany) ', 'Sklar Surgical Instruments (US) ', 'Karl Storz (Germany) ', 'Pentax Medical (Japan) ', 'Angiplast Pvt. Ltd. (India) ', 'Summit Medical LLC (US) ', 'Richard Wolf GmbH (Germany) ', 'Entermed (Spain) ', 'Schölly Fiberoptic GmbH (Germany) ', 'Xion GmbH (Germany) ', 'Cook Medical (US) ', 'Maxer Endoscopy GmbH (Germany) ', 'Esc Medicams (India)'

The increasing prevalence of sinusitis, a condition that commonly affects millions of people worldwide, is driving the demand for sinus dilators. Factors such as urbanization, environmental pollution and lifestyle changes contribute to the rise in respiratory problems, including sinusitis. Increasing awareness of the importance of treating chronic lung conditions and the availability of advanced surgical procedures are driving the market to grow with patients demanding more effective treatments, providing avenues for expansion the bladder is enlarged. 

Shift Towards Minimally Invasive Procedures: There is a distinct market trend in sinus dilation devices towards less invasive options. Patients and healthcare providers are increasingly demanding strategies that reduce recovery time and reduce complications. Balloon sinus dilation is a prime example of this trend, offering a less invasive alternative to traditional surgery. As more physicians adopt these options, the market for sinus dilation devices is expected to expand exponentially. 

North America dominates the sinus dilation devices market in terms of revenue, with a share of more than 45% in 2023. Highly regulated and streamlined healthcare can be attributed to this dominance and improved product because the presence of major market players boosts market growth. According to the Commonwealth Fund, the health care system in the U.S. is a combination of public and private companies. The federal government funds programs like Medicare for older adults with disabilities, as well as programs for veterans and low-income individuals like Medicaid and Children's Health Insurance Program States also administer several local payment and protection programs. Many people have private employer-provided health insurance, which is the most common form of coverage. The number of uninsured people has dropped over the years thanks to the Affordable Care Act. Public and private insurers decide what services are covered and how much individuals pay after a set of rules set by the federal and state governments.   

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Sinus Dilation Devices Market

Report ID: SQMIG35A2791

$5,300
BUY NOW GET FREE SAMPLE